These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 12615423)

  • 1. Author response to letter to the editor by Marciani et al.
    Liu G; Kensil CR
    Vaccine; 2003 Mar; 21(13-14):1303. PubMed ID: 12615423
    [No Abstract]   [Full Text] [Related]  

  • 2. Quillaja saponin adjuvants: derivatives formed under sub-optimal conditions.
    Marciani DJ; Pathak AK; Reynolds RD
    Vaccine; 2002 Sep; 20(27-28):3237-8. PubMed ID: 12213391
    [No Abstract]   [Full Text] [Related]  

  • 3. Solid-phase extraction NMR studies of chromatographic fractions of saponins from Quillaja saponaria.
    Nyberg NT; Baumann H; Kenne L
    Anal Chem; 2003 Jan; 75(2):268-74. PubMed ID: 12553761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leaf saponins of Quillaja brasiliensis enhance long-term specific immune responses and promote dose-sparing effect in BVDV experimental vaccines.
    Cibulski S; Rivera-Patron M; Suárez N; Pirez M; Rossi S; Yendo AC; de Costa F; Gosmann G; Fett-Neto A; Roehe PM; Silveira F
    Vaccine; 2018 Jan; 36(1):55-65. PubMed ID: 29174676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and synthesis of potent Quillaja saponin vaccine adjuvants.
    Adams MM; Damani P; Perl NR; Won A; Hong F; Livingston PO; Ragupathi G; Gin DY
    J Am Chem Soc; 2010 Feb; 132(6):1939-45. PubMed ID: 20088518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Foamy matters: an update on
    Magedans YV; Yendo AC; Costa F; Gosmann G; Fett-Neto AG
    Future Med Chem; 2019 Jun; 11(12):1485-1499. PubMed ID: 31304830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electrophoretic mobility as a tool to separate immune adjuvant saponins from Quillaja saponaria Molina.
    Gilabert-Oriol R; Weng A; von Mallinckrodt B; Stöshel A; Nissi L; Melzig MF; Fuchs H; Thakur M
    Int J Pharm; 2015 Jun; 487(1-2):39-48. PubMed ID: 25839418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation and characterisation of quillaja saponin with less heterogeneity than Quil-A.
    Kamstrup S; San Martin R; Doberti A; Grande H; Dalsgaard K
    Vaccine; 2000 Apr; 18(21):2244-9. PubMed ID: 10717344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification of an Immunoadjuvant Saponin Fraction from Quillaja brasiliensis Leaves by Reversed-Phase Silica Gel Chromatography.
    Yendo AC; de Costa F; Kauffmann C; Fleck JD; Gosmann G; Fett-Neto AG
    Methods Mol Biol; 2017; 1494():87-93. PubMed ID: 27718187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variation of saponin contents and physiological status in Quillaja saponaria under different environmental conditions.
    Grandón AS; Espinosa BM; Ríos DL; Sánchez OM; Sáez CK; Hernández SV; Becerra AJ
    Nat Prod Commun; 2013 Dec; 8(12):1697-700. PubMed ID: 24555275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrospray ionization ion-trap multiple-stage mass spectrometry of Quillaja saponins.
    Bankefors J; Broberg S; Nord LI; Kenne L
    J Mass Spectrom; 2011 Jul; 46(7):658-65. PubMed ID: 21706675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Saponin adjuvants. 3. Isolation of a substance from Quillaja saponaria Molina with adjuvant activity in food-and-mouth disease vaccines.
    Dalsgaard K
    Arch Gesamte Virusforsch; 1974; 44(3):243-54. PubMed ID: 4365900
    [No Abstract]   [Full Text] [Related]  

  • 13. Separation and characterization of saponins with adjuvant activity from Quillaja saponaria Molina cortex.
    Kensil CR; Patel U; Lennick M; Marciani D
    J Immunol; 1991 Jan; 146(2):431-7. PubMed ID: 1987271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant activity of Quillaja brasiliensis saponins on the immune responses to bovine herpesvirus type 1 in mice.
    Fleck JD; Kauffmann C; Spilki F; Lencina CL; Roehe PM; Gosmann G
    Vaccine; 2006 Nov; 24(49-50):7129-34. PubMed ID: 16887242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quillaja brasiliensis saponins are less toxic than Quil A and have similar properties when used as an adjuvant for a viral antigen preparation.
    Silveira F; Cibulski SP; Varela AP; Marqués JM; Chabalgoity A; de Costa F; Yendo AC; Gosmann G; Roehe PM; Fernández C; Ferreira F
    Vaccine; 2011 Nov; 29(49):9177-82. PubMed ID: 22001878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Constituents from leaves of Quillaja brasiliensis.
    Kauffmann C; Machado AM; Fleck JD; Provensi G; Pires VS; Guillaume D; Sonnet P; Reginatto FH; Schenkel EP; Gosmann G
    Nat Prod Res; 2004 Apr; 18(2):153-7. PubMed ID: 14984089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ISCOMs and immunostimulation with viral antigens.
    Höglund S; Dalsgaard K; Lövgren K; Sundquist B; Osterhaus A; Morein B
    Subcell Biochem; 1989; 15():39-68. PubMed ID: 2678618
    [No Abstract]   [Full Text] [Related]  

  • 18. Fractionation, structural studies, and immunological characterization of the semi-synthetic Quillaja saponins derivative GPI-0100.
    Marciani DJ; Reynolds RC; Pathak AK; Finley-Woodman K; May RD
    Vaccine; 2003 Sep; 21(25-26):3961-71. PubMed ID: 12922132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel ISCOMs from Quillaja brasiliensis saponins induce mucosal and systemic antibody production, T-cell responses and improved antigen uptake.
    Cibulski SP; Mourglia-Ettlin G; Teixeira TF; Quirici L; Roehe PM; Ferreira F; Silveira F
    Vaccine; 2016 Feb; 34(9):1162-71. PubMed ID: 26826546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of new immunoadjuvant saponin named QB-90, and analysis of its organ-specific distribution in Quillaja brasiliensis by HPLC.
    Fleck JD; de Costa F; Yendo AC; Segalin J; Dalla Costa TC; Fett-Neto AG; Gosmann G
    Nat Prod Res; 2013; 27(10):907-10. PubMed ID: 22404569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.